Dec 15 - Dec 17, 2013
Venue TBD
Scottsdale, AZ, USA
↓ Agenda Key
Visionary speaker presents to entire audience on key issues, challenges and business opportunities |
Panel moderated by Master of Ceremonies and headed by four executives discussing critical business topics | ||
Solution provider-led session giving high-level overview of opportunities |
End user-led session in boardroom style, focusing on best practices | ||
Interactive session led by a moderator, focused on industry issue |
Pre-determined, one-on-one interaction revolving around solutions of interest | ||
Discussion of business drivers within a particular industry area |
Moderator-led coverage of the latest industry research | ||
Several brief, pointed overviews of the newest solutions and services |
Overview of recent project successes and failures | ||
Informal discussions on pre-determined topics |
Unique activities at once relaxing, enjoyable and productive |
2:00pm
-
5:30pm
4:30pm
-
6:00pm
6:00pm
-
7:00pm
7:00pm
-
10:00pm
7:00am
-
8:00am
8:10am
-
8:50am
As organizations grow and reach a certain size, they frequently share a common characteristic. It is the affliction of the right hand not knowing what the left hand is doing. Incapable of reciprocal operation with other management systems, an information silo is a system steering towards its doom. The symptoms of the silo effect are easy to recognize: lack of cooperation, internal competition and breakdown in communication. What can we do to eliminate the silos? Knocking down the barriers can be an important contributor to value creation - and it will make way for sharing services, skills and systems across units, all the while encouraging best practices.
9:00am
-
9:30am
In order to be successful in an ever-evolving market, life sciences companies must be keenly aware of the latest IT and business trends impacting the industry; and quickly embrace and implement the IT solutions that will address the challenges of the business changes. Recent studies show that some of the issues of greatest concern to bio-pharmaceutical executives are the changing commercial business model, regulatory compliance, pipeline growth, fragmented business processes and access to accurate data. This presentation will discuss best practices for addressing these and other issues with innovative IT solutions that promote speed, flexibility, agility and collaboration. Cloud computing, mobility, analytics, digital profiling and other IT tools will be discussed.
9:35am
-
10:05am
Describing the role IT can play in supporting, governing and building the enterprise capability required to drive digital channel marketing success within a life sciences organization. This session walks through one successful approach for enabling effective partnerships between Brand teams, Agency and various service providers to deliver quality digital solutions.
10:10am
-
10:40am
Enterprises are convinced that they must embrace mobility and unlock its potential benefits. However, this area is still evolving and there are few best practices and standards. New tools, technologies and approaches are emerging frequently to address the enterprise needs. We will discuss the challenges faced by CIOs as they integrate mobile devices into the enterprise and also how they are pushing forward in spite of the nebulous environment. We will briefly cover the technology landscape and discuss how the pharmaceutical sector is committing to mobility programs that drive business value. We will close with a discussion of the high-priority enterprise mobile applications for pharmaceutical companies.
10:40am
-
11:05am
11:10am
-
11:40am
In this presentation we will discuss how we can deliver a unified data storage and management solution that can accelerate data ingestion from the instruments, increase the performance of an in-place sequencing pipeline - and have the ability to intelligently archive and share research data in a geographically distributed manner. We will also discuss how the use of high performance, scalable storage building blocks can deliver an array of flexible, highly scalable and easy to manage storage solutions that are helping research groups around the world accelerate their time to discover,y with innovative storage and archival solutions that have lowered the cost and simplified the processing,retention and management of the data life cycle.
11:45am
-
12:15pm
Big Pharma is famous for erecting security barriers second to none, but as the model for R&D shifts to one of extensive external partnership and collaboration, those same protective walls become impediments to change, advancing science, and, ostensibly, competitive advantage. Couple this with inconsistent data standards and the emergence of massive data sets, and it's a wonder we can collaborate at all!
In this open forum session, we will seek comments on a framework for external collaboration that leverages IT's rich history of governance and technology introduction, hopefully without also placing itself in the way of progress.
12:20pm
-
12:50pm
Given changes in the market for pharmaceuticals, the effective use of social media, collaboration tools, and mobility will be key for life science and pharmaceutical companies seeking to grow and innovate effectively with the market. This session will focus on the CIO agenda for Mobile, and how to stay on top of demand with a proactive Mobile strategy. We will share key lessons learned on how to promote innovation while maintaining control over digital initiatives.
12:55pm
-
1:55pm
2:00pm
-
2:30pm
Business process technology for R&D in life science organizations has lagged behind the commercial side in delivering transformational change, measurable efficiencies and stakeholder transparency. Technology for clinical development addresses one of the costliest and most critical life science activities, but must account for specialized functional silos, regulatory and QA skepticism, and multiple users. The result today is often a landscape of non-integrated, point solutions, often with significant implementation and support needs. With current industry pressures, the time is right to look to leverage lessons learned from the successful deployment of enterprise systems in commercial activities.
This presentation will address the use of technology to reach a future state of clinical development, where enterprise-like solutions, built on integrated, SaaS platforms, can support process change, business intelligence and real-time operational management.
2:35pm
-
3:05pm
The age of inexpensive genomic sequencing, imaging, and other large data generation is upon us. With the new research sciences are an exponential demand for more storage, compute and bandwidth. Traditional "best practices" get challenged as IT becomes either the new collaborative, innovative partner with the researchers, or becomes the slow, expensive roadblock to continued growth and competitiveness. In this session, we'll discuss various challenges and solutions around developing and managing multi-petabyte scale IT in Life Sciences Research.
3:10pm
-
3:40pm
Mobile security has evolved well past device restrictions and passcode policies. Enterprises must adopt and implement more advanced security techniques to protect sensitive content, mobile applications and access to internal enterprise and cloud services. The session will cover:
3:45pm
-
4:15pm
Time and information are business assets. Applied together, they can have a compounding effect on business value. In this session we will explore the value of time in applying information to opportunities and challenges. Learn how time has a compounding effect on the value of information, and hear examples of how some companies have benefited from that effect. We will introduce the concept to frame a discussion around strategies and technologies you can use in your organization to achieve breakthrough results.
Discover how you can reduce the time between business event and action and use that time to change your business.
4:25pm
-
4:55pm
5:00pm
-
5:30pm
5:30pm
-
7:00pm
7:00pm
-
9:30pm
9:30pm
-
10:30pm
7:30am
-
8:15am
8:20am
-
9:20am
The American Life Sciences industry are operating in an environment of unprecedented and unrelenting change. Companies are faced with harnessing the promise of great discoveries amid the challenges of increasing regulations, pricing pressures and heightened market and public expectations. Organizations must act quickly, responsibly and effectively to grow and pick market shares. What are the strategies Life Sciences organizations must adopt to achieve success over the next decade? This panel will discuss some of the challenges the CIOs will have to face, and how they can utilize innovative IT solutions to overcome them:
9:30am
-
10:00am
The Big Data sets created by the Healthcare System (academia, biopharma, government, healthcare delivery and payors) are creating opportunities and challenges to deliver more effective care and solutions. Consolidated data sets from multiple sources, providing a single version of the truth, need to implemented and maintained across disease spectrums - from the bench to the bedside. Over the past several years, new architectures (Cloud, hybrid FPGA and GPU), originally developed for the commercial markets, have gained an important foothold in research and development. Used in combination with traditional High Performance Computing (HPC) architectures they can significantly shorten discovery cycles. Efficient conversion of discoveries into effective medicines will require seamless integration of not only discovery and applied science, but also the exploratory and goal-oriented cultures in academia and industry. Effective Big Data research collaborations across academia, government, industry and healthcare delivery will create a cost effective Healthcare System.
10:05am
-
10:35am
Life Science companies have seen a set of massive paradigm shifts in recent years. These include consumerism and patient centricity through large increases in the cost of R&D, through pricing fluctuations and addressing revenue management. Therefore the need for better commercial operations.
To achieve this, there is a move towards "Commercial Excellence." During this session, we will share with you some perspectives on ways organizations can take positive steps internally with technology accelerators and at the same time keep watch of external influences to monitor and develop proactive strategies.
This interactive session will enable us to share our views with you, on the nine dimensions of Commercial Excellence and the technology accelerators that align with these dimensions. Participants are encouraged to share their experiences with CRM and Key Account Management, Enhancing the capabilities of the Sales Force, Multichannel Marketing, deploying and overseeing Social Media and other alterative channels.
10:40am
-
11:10am
Typically drugs have been repurposed following serendipitous observations. Now, however, there are a number of computational methods that can evaluate and suggest new indications for a drug. We will discuss some of these methods that are based on genetics, gene expression signatures, text-mining literature, and pathways.
11:10am
-
11:30am
11:35am
-
12:05pm
This open-forum session will discuss how personalized medicine - as defined by the concept of using genetic data and significant IT resources to provide specialized medicine for individual patients - is slowly moving into the Life Science and Healthcare mainstream, though only a few practical applications exist to date. When it does become more practical, it may be a financial blessing. New reports suggest that personalized medicine could provide significant ROI for all of the key stakeholders.
12:10pm
-
12:40pm
Clinical research and clinical care both seek to improve health outcomes. Traditional clinical research has focused on prospective studies to identify factors for improving care and prevention. Process improvement and quality initiatives seek to improve the delivery of care and optimize the patient experience for better individual outcomes. Both types of data can be effectively combined and mined using data warehousing. However, overseeing the appropriate use and interpretation of these data can be difficult. We will present one possible approach for handling clinical research data, identifying participants in the medical record, and one strategy for appropriately coupling high dimensional data such as genomic data to clinical outcomes.
12:45pm
-
1:45pm
1:50pm
-
2:20pm
2:25pm
-
3:05pm
The scale and breadth of the challenges facing the Life Sciences industry in the coming years are truly breathtaking. A changing health market, new regulatory pressures, even-higher hurdles for innovation and declining R&D productivity are all taking their toll on traditional business models and biomedical research.
Traditionally, pharmaceutical companies were bound by their organizational structure. IT services was aligned to the individual business units (i.e. R&D, Operations, Sales and Marketing), and provisioned directly to them. Today, the industry is responding in a number of ways, including moves towards new organization models in R&D and Commercial, a drive to lean operations and an increase in M&A and licensing activity. The Life Sciences industry must take a hard look at the way they perform IT operations and decide if these methods and solutions are sufficiently effective.
3:05pm
-
7:00pm
7:00pm
-
9:30pm
Download Dec 15 - Dec 17, 2013 Agenda (PDF)
Keynote Presentation